V
70
14
NI
63
5
VFC
56
6
KEY
24
2
KLAC
45
3
MAS
46
3
EXPD
29
2
THC
52
9
FTI
61
5
EXR
42
5
NRG
32
5
ALL
37
3
PPL
44
9
WFC
58
8
LRCX
56
4
AMAT
33
3
EQT
47
13
MHK
25
5
CVS
27
2
BIIB
36
8
V
70
14
NI
63
5
VFC
56
6
KEY
24
2
KLAC
45
3
MAS
46
3
EXPD
29
2
THC
52
9
FTI
61
5
EXR
42
5
NRG
32
5
ALL
37
3
PPL
44
9
WFC
58
8
LRCX
56
4
AMAT
33
3
EQT
47
13
MHK
25
5
CVS
27
2
BIIB
36
8
Financhill
Back

Eli Lilly and 10K Form

Sell
37

LLY
Eli Lilly and

Last Price:
$768.11
Seasonality Move:
3.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LLY News And Ratings

See the #1 stock for the next 7 days that we like better than LLY

LLY Financial Statistics

Sales & Book Value

Annual Sales: $34.1B
Cash Flow: $-458.9M
Price / Cash Flow: 0
Annual Sales: $15.82
Price / Book: 51.18

Profitability

EPS (TTM): 9.25000
Net Income (TTM): $8.4B
Gross Margin: $27B
Return on Equity: 66.4%
Return on Assets: 12.55%

Eli Lilly and Earnings Forecast

Key Eli Lilly and Financial Ratios

  • The Gross Profit Margin over the past 40 years for LLY is 79.25%.
  • The Selling, General & Administrative Expenses for LLY have been equal to 20.34% of Gross Profit Margin.
  • The Research & Development expenses have been 27.29% of Revenue.
  • The Interest Expense is 9.27% of Operating Income.
  • The Net Earning history of LLY is 15.36% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 23 years.

Eli Lilly and Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: LLY
CUSIP: 532457
Website: lilly.com

Debt

Debt-to-Equity Ratio: 2.19
Current Ratio: 1.27
Quick Ratio: 0.63

Price-to-Earnings

Trailing P/E Ratio: 132.37
Forward P/E Ratio: 33.95

LLY Technical Analysis vs Fundamental Analysis

Sell
37
Eli Lilly and (LLY) is a Sell

Is Eli Lilly and a Buy or a Sell?

  • Eli Lilly and stock is rated a Sell
    The current Eli Lilly and [LLY] share price is $767.76. The Score for LLY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.